{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:32:53Z","timestamp":1793197973655,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jim.2021.113172","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T20:53:43Z","timestamp":1634676823000},"page":"113172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Brucella antigens (BhuA, 7\u03b1-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis"],"prefix":"10.1016","volume":"500","author":[{"given":"Zohre","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fasihi-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2021.113172_bb0005","first-page":"11","article-title":"A recombinant chimera protein as a novel Brucella subunit vaccine: protective efficacy and induced immune response in BALB\/c mice","volume":"21","author":"Abdollahi","year":"2017","journal-title":"Evaluation"},{"issue":"8","key":"10.1016\/j.jim.2021.113172_bb0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apm.12400","article-title":"Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections","volume":"123","author":"Abkar","year":"2015","journal-title":"Apmis"},{"issue":"1","key":"10.1016\/j.jim.2021.113172_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.20506\/rst.32.1.2187","article-title":"Epidemiology of brucellosis in domestic animals caused by Brucella melitensis, Brucella suis and Brucella abortus","volume":"32","author":"Aparicio","year":"2013","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"10.1016\/j.jim.2021.113172_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/743509","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calder\u00f3n","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"1\u20134","key":"10.1016\/j.jim.2021.113172_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0378-1135(02)00222-5","article-title":"Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection","volume":"90","author":"Baldwin","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jim.2021.113172_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-animal-021815-111326","article-title":"Brucella spp. virulence factors and immunity","volume":"4","author":"Byndloss","year":"2016","journal-title":"Annual Rev. Animal Biosci."},{"issue":"2","key":"10.1016\/j.jim.2021.113172_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2012.11.009","article-title":"Poly (I: C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs","volume":"97","author":"Cao","year":"2013","journal-title":"Antivir. Res."},{"issue":"10","key":"10.1016\/j.jim.2021.113172_bb0040","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.jim.2021.113172_bb0045","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.jim.2021.113172_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jim.2021.113172_bb0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis: review of Brucella\u2013host interactions","volume":"185","author":"de Figueiredo","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1\u20134","key":"10.1016\/j.jim.2021.113172_bb0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0378-1135(02)00223-7","article-title":"The innate immune response against Brucella in humans","volume":"90","author":"Dornand","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.jim.2021.113172_bb0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet. Res."},{"issue":"31","key":"10.1016\/j.jim.2021.113172_bb0070","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.vaccine.2015.05.057","article-title":"Immune response triggered by Brucella abortus following infection or vaccination","volume":"33","author":"Dorneles","year":"2015","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.jim.2021.113172_bb0075","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.vaccine.2014.09.013","article-title":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection","volume":"32","author":"Ghasemi","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jim.2021.113172_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice","volume":"62","author":"Ghasemi","year":"2014","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2021.113172_bb0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molimm.2015.01.009","article-title":"Vaccination with recombinant L7\/L12-truncated Omp31 protein induces protection against Brucella infection in BALB\/c mice","volume":"65","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.jim.2021.113172_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijmm.2017.03.004","article-title":"Protein\/protein, DNA\/DNA and DNA\/protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB\/c mice","volume":"307","author":"Golshani","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.jim.2021.113172_bb0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molimm.2018.10.002","article-title":"Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7\/L12+ rTOmp31+ rSOmp2b) in two different adjuvant formulations in BALB\/c mice","volume":"103","author":"Golshani","year":"2018","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.jim.2021.113172_bb0100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly (I: C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jim.2021.113172_bb0105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4014\/jmb.1505.05028","article-title":"Immunization of mice with recombinant Brucella abortus organic hydroperoxide resistance (Ohr) protein protects against a virulent Brucella abortus 544 infection","volume":"26","author":"Hop","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.jim.2021.113172_bb0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"Martins","year":"2015","journal-title":"Expert Rev. Vacc."},{"issue":"7","key":"10.1016\/j.jim.2021.113172_bb0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3: interferon induction by double-stranded RNA including poly (I: C)","volume":"60","author":"Matsumoto","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.jim.2021.113172_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12538","article-title":"Th1 immune response to plasmodium falciparum recombinant thrombospondin-related adhesive protein (TRAP) antigen is enhanced by TLR3-specific adjuvant, poly (I: C) in BALB\/c mice","volume":"40","author":"Mehrizi","year":"2018","journal-title":"Parasite Immunol."},{"issue":"2","key":"10.1016\/j.jim.2021.113172_bb0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2004.12.009","article-title":"Interferon-\u03b3 associated cytokines and chemokines produced by spleen cells from Brucella-immune mice","volume":"30","author":"Paranavitana","year":"2005","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.jim.2021.113172_bb0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.jim.2021.113172_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"issue":"17\u201319","key":"10.1016\/j.jim.2021.113172_bb0140","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","article-title":"Reverse vaccinology, a genome-based approach to vaccine development","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2021.113172_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbiotec.2020.01.016","article-title":"Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection","volume":"310","author":"Sadeghi","year":"2020","journal-title":"J. Biotechnol."},{"issue":"45","key":"10.1016\/j.jim.2021.113172_bb0150","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1016\/j.vaccine.2010.08.098","article-title":"Poly (I: C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to plasmodium falciparum circumsporozoite protein (CSP) and \u03b1DEC-CSP in non human primates","volume":"28","author":"Tewari","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.jim.2021.113172_bb0155","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.jim.2021.113172_bb0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/omi.2015.0105","article-title":"Novel vaccine candidates against brucella melitensis identified through reverse vaccinology approach","volume":"19","author":"Vishnu","year":"2015","journal-title":"Omics"},{"key":"10.1016\/j.jim.2021.113172_bb0165","first-page":"1302561","article-title":"Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis","author":"Vitry","year":"2014","journal-title":"J. Immunol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:38:25Z","timestamp":1758299905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175921002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"alternative-id":["S0022175921002179"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2021.113172","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brucella antigens (BhuA, 7\u03b1-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2021.113172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113172"}}